Workflow
鲁 泰A: 关于出售金融资产情况的公告
Zheng Quan Zhi Xing·2025-06-25 18:27

Core Viewpoint - The company, Lutai Textile Co., Ltd., plans to sell its shares in Rongchang Biological to improve asset liquidity and efficiency, and to meet operational funding needs. The sale will be conducted through the secondary market at a reasonable price range, with specific details such as timing and transaction amounts remaining uncertain [1][5]. Transaction Overview - The company holds 3,918,265 shares of Rongchang Biological, accounting for 1.25% of its total equity. The sale does not require board approval and does not constitute a related party transaction or a major asset restructuring [2][3]. - The estimated profit from the stock sale is projected to impact the company's net profit by approximately 81.04 million yuan, exceeding 10% of the audited net profit for the last fiscal year, thus meeting disclosure standards [2][3]. Basic Information of the Transaction Target - Rongchang Biological was established on July 4, 2008, and is located in Yantai, Shandong. It focuses on the discovery, development, and commercialization of innovative biopharmaceuticals for major diseases [3]. - As of March 31, 2025, Rongchang Biological's total assets were approximately 5.5 billion yuan, with total liabilities of about 3.5 billion yuan, resulting in a net asset value of approximately 1.99 billion yuan [4]. Purpose and Impact of Asset Sale - The primary goal of selling the shares is to reduce the proportion of financial assets and to meet the company's funding requirements. The proceeds will be used to supplement working capital [5]. - The company currently holds 612,600 shares of Rongchang Biological, and while the sale may affect current profits, the final impact remains uncertain due to market volatility [5].